Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Omeros CorporationNASDAQ: OMER
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses declines year over year
Q1 FY2026 operating expenses of $26.49M fell 24.3% year over year, ahead of the -36.9% change in trailing-twelve-month operating expenses. Sequentially, it fell 8.9% from the prior quarter. Over 3 fiscal years it compounded at -9.1% a year.
Context
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -24.3% holds above the trailing-twelve-month pace of -36.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 122.8M USD
- Year-over-year change
- -27.5%
- 4-year CAGR
- -8.1%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 122.8M | -27.5% |
| FY2024 | 2024-12-31 | 169.26M | +2.9% |
| FY2023 | 2023-12-31 | 164.53M | +0.7% |
| FY2022 | 2022-12-31 | 163.39M | -5.1% |
| FY2021 | 2021-12-31 | 172.23M | — |
Operating Expenses vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 operating expenses of $104.02M is the 8th highest of the 11 companies compared; the peer median is $207.6M.
- Its year-over-year change of -36.9% is the lowest of 11, against a peer median of +6.5%.
- Operating expenses amounts to 1051.5% of revenue for OMER, versus a peer median of 249.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $596M | -0.7% | +16.7% | 509.4% | |
| LTM Jun 2026 | $565.38M | -29.4% | +9.3% | — | |
| LTM Jun 2026 | $261.54M | +14.7% | +83.3% | 249.1% | |
| LTM Mar 2026 | $240.35M | +15.1% | — | — | |
| LTM Mar 2026 | $229.74M | +420.0% | +71.3% | 98.9% | |
| LTM Jun 2026 | $185.46M | +13.6% | -15.7% | 339.7% | |
| LTM Mar 2026 | $173.51M | -10.6% | -12.1% | 110.5% | |
| LTM Mar 2026 | $104.02M | -36.9% | -9.1% | 1051.5% | |
| LTM Mar 2026 | $47.9M | +53.4% | +9.6% | — | |
| LTM Mar 2026 | $37.72M | -21.8% | -10.5% | 7543.6% | |
| LTM Mar 2026 | $33.28M | -2.6% | -8.4% | 45.8% | |
| Peer median (excluding OMER) | $207.6M | +6.5% | +9.3% | 249.1% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| Weighted Avg Shares | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
| Weighted Avg Shares (Diluted) | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.